MedPath
NMPA Approval

Recombinant Human Follitropin for Injection

国药准字SJ20181008

January 16, 2023

S20181008

Drug Information

注射用重组人促卵泡激素

果纳芬

注射剂

5.5μg(75IU)

生物制品

January 16, 2023

January 15, 2028

Company Information

Applicant Company

Merck Europe BV

Gustav Mahlerplein 102, 1082 MA Amsterdam, The Netherlands

Manufacturing Company

merck serono sa, succursale d'aubonne

Zone Industrielle de l'Ouriettaz, 1170 Aubonne, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人促卵泡激素 - NMPA 批准文号 | MedPath